Heterogeneity assessment and diffusion weighted magnetic resonance imaging (DW-MRI) have been considered powerful diagnostic tools in predicting chemoradiotherapy treatment outcome in patients with cancer. In this study, pre-treatment microstructural heterogeneity derived by intra- and inter-voxel MR diffusion rates was assessed in patients with neck squamous cell carcinoma (HNSCC). A correlation was presented between the pre-treatment MR diffusion heterogeneity and the chemoradiotherapy treatment outcome of patients with HNSCC. Future work, to ascertain the mechanisms of these correlations would open the opportunity to tailor therapies to individuals in clinical practice.
This abstract and the presentation materials are available to members only; a login is required.